GENESIS Pharma is a European biopharmaceutical company specializing in the commercialization of innovative pharmaceutical products for serious and rare diseases. Established in 1997, GENESIS Pharma was the first pharmaceutical company in Greece and one of the first in Europe to focus on the sales, marketing and distribution of biopharmaceutical products. Shortly after its founding, the company began to steadily expand at a regional level, currently covering 24 countries in Europe. The robust network of its strategic partnerships comprises leading international pharmaceutical companies dedicated to cutting-edge R&D, alongside fast-growing biopharmaceutical companies with pioneering research and disruptive innovations in the development of targeted, specialized treatments for orphan diseases. In total, GENESIS Pharma holds a product portfolio covering over 30 serious and rare diseases.
| Website | https://www.genesispharma.com |
| Revenue | $18.4 million |
| Employees | 204 (143 on RocketReach) |
| Founded | 1997 |
| Address | 270 Kifissias Avenue Halandri, Athens 15232, GR |
| Phone | +385 1 5530 011 |
| Fax | +357 22 765714 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Central Nervous System, Retail, Oncology, Haematology, Nephrology, Rheumatology, Gastroenterology, Biotechnology |
| Web Rank | 4 Million |
| Keywords | Biopharmaceutical, Pharmaceutical Products, Rare Diseases, Serious Diseases, Drug Commercialization, Innovative Medicines, Drug Development, Pharmaceutical Research, Biotechnology, Pharma, Specialty Pharmaceuticals, Clinical Trials, Drug Manufacturing, Fda Approval, Healthcare, Prescription Drugs, Pharmaceutical Sales, Global Pharma |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Genesis Pharma employee's phone or email?
The Genesis Pharma annual revenue was $18.4 million in 2026.
Costas Evripides is the CEO and Founding Member of Genesis Pharma.
143 people are employed at Genesis Pharma.
The NAICS codes for Genesis Pharma are [32541, 325, 3254, 32].
The SIC codes for Genesis Pharma are [283, 28].